FDx Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,256
| Closed | -$220K | – | 426 |
|
|
2023
Q4 | $220K | Buy |
3,256
+282
| +9% | +$19.1K | 0.02% | 627 |
|
|
2023
Q3 | $215K | Buy |
2,974
+344
| +13% | +$24.9K | 0.02% | 583 |
|
|
2023
Q2 | $196K | Buy |
2,630
+1,235
| +89% | +$92K | 0.01% | 719 |
|
|
2023
Q1 | $94K | Hold |
1,395
| – | – | ﹤0.01% | 734 |
|
|
2022
Q4 | $94K | Buy |
1,395
+141
| +11% | +$9.5K | ﹤0.01% | 734 |
|
|
2022
Q3 | $156K | Buy |
1,254
+56
| +5% | +$6.97K | 0.01% | 701 |
|
|
2022
Q2 | $114K | Buy |
1,198
+267
| +29% | +$25.4K | ﹤0.01% | 789 |
|
|
2022
Q1 | $150K | Buy |
+931
| New | +$150K | 0.01% | 806 |
|